NanoVibronix (NASDAQ:NAOV) Stock Price Passes Below Fifty Day Moving Average of $0.67

Shares of NanoVibronix, Inc. (NASDAQ:NAOVGet Rating) passed below its fifty day moving average during trading on Thursday . The stock has a fifty day moving average of $0.67 and traded as low as $0.64. NanoVibronix shares last traded at $0.66, with a volume of 89,347 shares traded.

NanoVibronix Price Performance

The firm’s 50-day simple moving average is $0.67 and its 200 day simple moving average is $0.75.

NanoVibronix (NASDAQ:NAOVGet Rating) last posted its quarterly earnings results on Tuesday, May 17th. The company reported ($0.04) earnings per share (EPS) for the quarter. The business had revenue of $0.27 million during the quarter. NanoVibronix had a negative net margin of 563.14% and a negative return on equity of 110.50%.

Hedge Funds Weigh In On NanoVibronix

A number of hedge funds and other institutional investors have recently bought and sold shares of NAOV. State Street Corp grew its stake in NanoVibronix by 32.1% in the 1st quarter. State Street Corp now owns 125,390 shares of the company’s stock worth $145,000 after buying an additional 30,500 shares in the last quarter. Amtrust Financial Services Inc. grew its stake in NanoVibronix by 69.8% in the 4th quarter. Amtrust Financial Services Inc. now owns 248,148 shares of the company’s stock worth $258,000 after buying an additional 102,000 shares in the last quarter. Finally, Vanguard Group Inc. grew its stake in NanoVibronix by 53.7% in the 1st quarter. Vanguard Group Inc. now owns 651,262 shares of the company’s stock worth $755,000 after buying an additional 227,454 shares in the last quarter. Hedge funds and other institutional investors own 6.80% of the company’s stock.

About NanoVibronix

(Get Rating)

NanoVibronix, Inc, through its subsidiary, NanoVibronix Ltd., focuses on the manufacture and sale of noninvasive biological response-activating devices that target biofilm prevention, wound healing, and pain therapy. Its principal products include UroShield, an ultrasound-based product to prevent bacterial colonization and biofilm in urinary catheters, enhance antibiotic efficacy, and decrease pain and discomfort associated with urinary catheter use; PainShield, a patch-based therapeutic ultrasound technology to treat pain, muscle spasm, and joint contractures; and WoundShield, a patch-based therapeutic ultrasound device, which facilitates tissue regeneration and wound healing.

Further Reading

Receive News & Ratings for NanoVibronix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NanoVibronix and related companies with MarketBeat.com's FREE daily email newsletter.